Group 1 - The company approved a guarantee limit of RMB 33.669 billion for 2025, which includes various forms of guarantees such as asset pledges and guarantees for subsidiaries and joint ventures [2][3] - The company has allocated a guarantee limit of RMB 32.901 billion for subsidiaries with a debt-to-asset ratio below 70%, and RMB 21.159 billion for those above 70% [2] - The company has not incurred any overdue guarantees or legal disputes related to guarantees as of the announcement date [11] Group 2 - The company plans to use up to RMB 1.2 billion of idle funds for entrusted wealth management, which is valid for 12 months from the board's approval [17][28] - The investment will focus on low-risk financial products with high liquidity, avoiding high-risk investments such as securities and derivatives [28][32] - The company aims to enhance the efficiency of idle funds and increase returns for shareholders while ensuring normal business operations [30][39] Group 3 - The company held its ninth board meeting on January 23, 2026, where several resolutions were passed, including changes to the business scope and amendments to the articles of association [12][13] - The company will convene its first extraordinary general meeting of 2026 on February 9, 2026, to review the board's proposals [42][43] - The meeting will allow shareholders to vote both in person and online, with specific registration and voting procedures outlined [45][56]

登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 二、与会计师事务所沟通情况 证券代码：002393 证券简称：力生制药 公告编号：2026-005 天津力生制药股份有限公司 2025年度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日-2025年12月31日 2、预计的业绩： √同向上升 3、业绩预告为区间 本次业绩预告相关数据是公司财务部门初步测算的结果，未经会计师事务所审计。公司已就业绩预告有 关事项与年报审计会计师事务所进行了预沟通，公司与会计师事务所在本报告期的业绩预告方面不存在 分歧。 三、业绩变动原因说明 报告期内，公司持续加大市场拓展力度，产品销售有所提升；加之天士力生物医药产业集团有限公司分 红因素影响，归属于上市公司股东的净利润同比增幅较大。 四、其他相关说明 本次业绩预告是公司财务部门初步核算的结果，具体财务数据以公司披露的2025年度报告为准。敬请广 大投资者审慎决策，注意投资风险。 特此公告。 天津力生制药股份有限公司 董事会 2026年01月24日 ...

Group 1 - The company is conducting a board of directors election as the current board's term is about to expire, in accordance with the Company Law and its Articles of Association [1][2][3] - The sixth board will consist of 9 directors, including 3 independent directors and 1 employee representative director, who will be elected by the employee representative assembly [2][3] - The candidates for the sixth board include five non-independent directors and three independent directors, with the election to be held at the company's first extraordinary general meeting in 2026 [2][3][4] Group 2 - The nomination committee has reviewed the qualifications of the candidates, confirming that they meet the necessary requirements and have not faced any disqualifications under relevant laws and regulations [3][6][7] - The independent director candidates do not hold shares in the company and have no relationships with significant shareholders or other directors, ensuring their independence [3][6][7] - The current board will continue to fulfill its responsibilities until the new board is officially appointed [3][4] Group 3 - The company plans to hold its first extraordinary general meeting on February 9, 2026, where shareholders will vote on the proposed board candidates [43][44] - The voting will be conducted through a combination of on-site and online methods, utilizing the Shanghai Stock Exchange's voting system [44][46] - Shareholders must register to attend the meeting, with specific guidelines provided for both individual and corporate shareholders [56][58]

Group 1 - The company is preparing for the election of the seventh board of directors, with the current board's term ending soon [1][2] - The board has nominated six candidates for non-independent directors and four candidates for independent directors, pending approval from the Shanghai Stock Exchange [2][3] - The independent director candidates' qualifications will be reviewed by the Shanghai Stock Exchange before being submitted for shareholder voting [2][3] Group 2 - The sixth board of directors has been recognized for their diligence and contributions to the company's development during their term [4] - The company will hold its first extraordinary general meeting of 2026 on February 9, 2026, to vote on the proposed board candidates and other matters [24][36] - The voting will utilize a cumulative voting system for the election of directors [40][52] Group 3 - The company is adjusting its business scope to include the operation and storage of hazardous chemicals, in addition to its existing operations [14][18] - The amendments to the company's articles of association will reflect these changes and will also be submitted for shareholder approval [14][18] Group 4 - The company has provided detailed resumes of the nominated candidates for both non-independent and independent director positions, highlighting their qualifications and lack of conflicts of interest [5][10][33] - The candidates include individuals with extensive experience in finance, management, and industry-specific expertise [5][10][33]

Core Viewpoint - The company, Zhejiang Hongqiao Shoes Co., Ltd., is forecasting a significant net loss for the year 2025, indicating ongoing challenges in the traditional fashion footwear market [1][2]. Group 1: Performance Forecast - The company expects a net profit attributable to shareholders of the parent company to be between -100 million yuan and -150 million yuan for the year 2025 [2]. - The forecasted net profit, excluding non-recurring gains and losses, is projected to be between -129 million yuan and -179 million yuan [2]. - The performance forecast period is from January 1, 2025, to December 31, 2025 [1]. Group 2: Previous Year Performance - In the same period last year, the net profit attributable to shareholders was -70.34 million yuan, and the net profit excluding non-recurring gains and losses was -79.75 million yuan [4]. - The earnings per share for the previous year were -0.12 yuan [5]. Group 3: Reasons for Performance Decline - The primary reasons for the expected loss include weak consumer demand in the traditional fashion footwear sector and intensified competition, leading to a decline in operating revenue compared to the previous year [6]. - The company plans to focus on a customer-centric approach, implement a "big product" strategy, and continuously optimize its product structure to improve performance [6]. - The company aims to enhance operational efficiency by leveraging digital tools and embracing new channels and business models [6].

Group 1 - The company reported a preliminary financial data for the year 2025, which is subject to final audit and may differ from the final report [1][4] - The company achieved an operating revenue of 4.22 billion yuan, a decrease of 4.87% year-on-year [3] - The net profit attributable to shareholders of the listed company was 906 million yuan, reflecting a year-on-year increase of 14.96% [3] Group 2 - The company is focusing on brand building and strengthening its core business through "big single products and strong categories" [3] - Marketing strategies have been enriched, with an emphasis on return on investment and optimizing cost structures [3] - The company is implementing lean manufacturing to reduce costs and improve efficiency, contributing to the enhancement of profitability [3]

Core Viewpoint - The company has successfully completed the repayment of its second phase of ultra-short-term financing bonds for the year 2025, with a total principal and interest repayment amounting to approximately RMB 506.29 million [2]. Group 1 - The company issued the second phase of ultra-short-term financing bonds on April 25, 2025, with a total issuance amount of RMB 500 million, a term of 270 days, and an annual interest rate of 1.70% [1]. - The repayment date for the bonds is set for January 23, 2026, with provisions for extension in case of public holidays [1]. - The repayment was facilitated by the National Interbank Market Clearing House Co., Ltd., which transferred the funds to the designated bank accounts of the bondholders [2].

关于副总裁离任的公告 本公司及董事会全体成员保证公告内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 深圳华侨城股份有限公司（以下简称"公司"）董事会近日收到公司副总裁倪明涛先生递交的书面辞职报 告，倪明涛先生因个人原因辞去公司副总裁职务，离任后将不再担任公司任何职务。 证券代码： 000069 证券简称：华侨城A 公告编号：2026-06 债券代码：149439 债券简称：21侨城06 133811 24侨城01 深圳华侨城股份有限公司 倪明涛先生的辞职报告自送达董事会之日起生效，其离任后不会对公司的正常生产经营活动造成影响。 截至本公告日，倪明涛先生未持有公司股票。 特此公告。 深圳华侨城股份有限公司 董 事 会 二〇二六年一月二十四日 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 牡丹江恒丰纸业股份有限公司（以下简称"公司"）董事会于2026年1月19日以书面形式和电子邮件等方 式，向公司董事发出召开十一届董事会第十六次会议的通知。会议于2026年1月22日以通讯表决的方式 召开，会议应出席董事9人，实际出席董事9人。经与会董事审议，以6票同意、0票反对、0票弃权,审议 通过了《关于公司2026年度预计日常关联交易金额的议案》，关联董事李迎春、梁德权、周再利回避表 决。本议案在董事会审批权限范围内，无需提交股东会审议。本议案在提交董事会审议前已经独立董事 专门会议审议通过，一致同意提交董事会审议。 （二）公司2025年度日常关联交易的预计情况和执行情况 2025年日常关联交易全年预计金额17,770万元，2025年实际发生金额14，117.23万元，全年未超过股东 会授权金额。具体情况如下： ■ 牡丹江恒丰纸业集团有限责任公司为本公司控股股东，根据《上海证券交易所股票上市规则 ...

重要提示：本公司提示并请投资者注意，上表所列的2025年生产经营数据反映本公司目前的统计结果， 尚未经过审计。本公司将在年度报告中披露经审计的数据，如与以上数据存在差异，以年度报告披露为 准。 中国石油化工股份有限公司 2025年生产经营业绩提示性公告 中国石化董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 ■ 注：境内合资企业产品产量按100%口径统计 股票代码：600028 股票简称：中国石化 公告编号：2026-02 特此公告。 承董事会命 副总裁、董事会秘书 黄文生 2026年1月23日 ...